Human medicines European public assessment report (EPAR): Doptelet, avatrombopag, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): Xromi, hydroxycarbamide, Date of authorisation: 01/07/2019, Revision: 11, Status: Authorised
Human medicines European public assessment report (EPAR): Prolia, denosumab, Date of authorisation: 26/05/2010, Revision: 33, Status: Authorised
Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - April 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 April 2025, 11:00 (CEST) to 29 April 2025, 12:00 (CEST)
Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - March 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 March 2025, 11:00 (CET) to 25 March 2025, 12:00 (CET)
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 18 February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 February 2025, 11:00 (CET) to 18 February 2025, 12:00 (CET)
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 13 February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 February 2025, 10:30 (CET) to 13 February 2025, 11:15 (CET)
Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 4 February 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 4 February 2025, 11:00 (CET) to 4 February 2025, 11:45 (CET)
Concept paper on the new reflection paper on the clinical investigation of medicinal products for the treatment of systemic sclerosis
Antimicrobial Sales and Use (ASU) Platform: Release notes